← brief for 2026-08-10 · Slowing decline

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

Trial No results yet Not peer reviewed

Key takeaways

A large phase 3 trial is starting to test a drug called elecoglipron against a placebo (dummy pill) in adults with type 2 diabetes and reduced kidney function. Everyone also takes dapagliflozin, a standard kidney-protecting drug. The study is just beginning, so there are no results yet.

Who did this work

Run by AstraZeneca.
Sites: Research Site

Source

Trial registration · ClinicalTrials.gov — CKD recruiting · 2026-08-04
https://clinicaltrials.gov/study/NCT07662135